Literature DB >> 15251684

Mediastinal parathyroid carcinoma.

S E Delaney1, R A Wermers, G B Thompson, S F Hodgson, S F Dinneen.   

Abstract

OBJECTIVE: To describe a patient with a mediastinal parathyroid carcinoma and hypercalcemia as well as to compare the features of parathyroid carcinoma with those of hypercalcemia due to other causes of primary hyperparathyroidism.
METHODS: We present a case report and discuss the diagnosis and management of this rare tumor.
RESULTS: In a 44-year-old man, severe hypercalcemia and normal findings on neck exploration led to referral and ultimate detection of an anterior mediastinal mass. Surgical resection and pathologic examination of the mass revealed a cystic parathyroid carcinoma. Subsequently, normalization of serum calcium and parathyroid hormone levels ensued.
CONCLUSION: Parathyroid carcinoma as an alternative to the diagnosis of primary hyperparathyroidism should be considered in patients with dramatically increased serum calcium and parathyroid hormone levels at the time of initial examination. The mainstay of therapy for parathyroid carcinoma is complete surgical resection. Accurate preoperative localization of parathyroid carcinoma is helpful, especially in instances of reoperation or hypercalcemic crisis.

Entities:  

Year:  1999        PMID: 15251684     DOI: 10.4158/EP.5.3.133

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  3 in total

1.  Parathyroid carcinoma: A rare case with mandibular brown tumor.

Authors:  Payam S Pahlavan; Marianne C Severin
Journal:  Wien Klin Wochenschr       Date:  2006-04       Impact factor: 1.704

2.  Mediastinal parathyroid carcinoma presenting with severe skeletal manifestations.

Authors:  Tuck Y Yong; Jordan Y Z Li
Journal:  J Bone Miner Metab       Date:  2010-03-18       Impact factor: 2.626

Review 3.  Persistent Hypercalcemia Crisis and Recurrent Acute Pancreatitis Due to Multiple Ectopic Parathyroid Carcinomas: Case Report and Literature Review of Mediastinal Parathyroid Carcinoma.

Authors:  Ruizhi Jiajue; An Song; Ou Wang; Wei Li
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-10       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.